基本信息
views: 7
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Leonard is a pharmacoepidemiologist with expertise in post-market drug safety. He is internationally known for his work in the comparative safety of medical products, especially among economically disadvantaged and older adult populations. He has presented his work in this area to: field leaders at national and international conferences; federal regulators and policymakers at FDA, AHRQ, and CDC; colleagues at universities and institutions at home and abroad; and to clinical decision support stakeholders at health information technology firms.
Research Interests
Papers共 264 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Clinical pharmacology and therapeuticsno. 1 (2024): 117-127
Emily K Acton,Sean Hennessy, Michael A Gelfand,Charles E Leonard, Warren B Bilker,Di Shu, Allison W Willis,Scott E Kasner
Clinical pharmacology and therapeuticsno. 2 (2024): 448-459
Emily K Acton,Sean Hennessy, Michael A Gelfand,Charles E Leonard,Warren B Bilker,Di Shu,Allison W Willis,Scott E Kasner
JAMA neurology (2024)
Journal of the American College of Cardiologyno. 13 (2024): 1323
Pharmacoepidemiology and drug safetyno. 1 (2023): e5678-e5678
Journal of Autism and Developmental Disorderspp.1-9, (2023)
Thanh Phuong Pham Nguyen,Sean Hennessy,Colleen M. Brensinger,Warren Bilker,Laura M. Dember,Todd Miano,Allison W. Willis,Charles E. Leonard
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023): 64-65
Cited0Views0Bibtex
0
0
Journal of hospital medicineno. 9 (2023): 812-821
Crohn's & colitis 360no. 3 (2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn